3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:百万円) |
| 前連結会計年度 (2025年3月31日) | 当連結会計年度 (2026年3月31日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 45,471 | 45,306 |
受取手形及び売掛金 | 61,449 | 63,283 |
電子記録債権 | 10,496 | 10,898 |
商品及び製品 | 44,770 | 54,255 |
仕掛品 | 18,648 | 20,038 |
原材料及び貯蔵品 | 44,869 | 49,132 |
デリバティブ債権 | 10,791 | 16,175 |
その他 | 11,123 | 8,432 |
貸倒引当金 | △314 | △179 |
流動資産合計 | 247,306 | 267,343 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物(純額) | 76,073 | 86,575 |
機械装置及び運搬具(純額) | 18,367 | 20,458 |
土地 | 18,259 | 18,586 |
リース資産(純額) | 11,802 | 12,921 |
建設仮勘定 | 40,089 | 27,387 |
その他(純額) | 3,830 | 4,715 |
有形固定資産合計 | 168,423 | 170,643 |
無形固定資産 | | |
のれん | 28,115 | 9,468 |
製造販売権 | 7,473 | 7,124 |
技術関連資産 | 5,489 | 4,675 |
その他 | 4,764 | 5,411 |
無形固定資産合計 | 45,842 | 26,680 |
投資その他の資産 | | |
投資有価証券 | 871 | 957 |
関係会社株式 | 506 | 520 |
繰延税金資産 | 6,037 | 6,136 |
その他 | 2,684 | 3,880 |
貸倒引当金 | △848 | △873 |
投資その他の資産合計 | 9,250 | 10,622 |
固定資産合計 | 223,517 | 207,946 |
資産合計 | 470,823 | 475,290 |
| | (単位:百万円) |
| 前連結会計年度 (2025年3月31日) | 当連結会計年度 (2026年3月31日) |
負債の部 | | |
流動負債 | | |
支払手形及び買掛金 | 17,918 | 21,309 |
電子記録債務 | 12,123 | 12,034 |
短期借入金 | 4,699 | 7,100 |
1年内返済予定の長期借入金 | 18,023 | 21,772 |
リース債務 | 1,383 | 1,699 |
未払金 | 15,482 | 17,290 |
未払法人税等 | 4,852 | 4,766 |
役員賞与引当金 | 112 | 97 |
設備関係支払手形 | 5,358 | 2,217 |
設備関係未払金 | 3,714 | 1,301 |
その他 | 4,270 | 7,276 |
流動負債合計 | 87,939 | 96,867 |
固定負債 | | |
長期借入金 | 195,077 | 183,335 |
リース債務 | 11,801 | 12,829 |
退職給付に係る負債 | 141 | 132 |
その他 | 4,237 | 4,019 |
固定負債合計 | 211,259 | 200,318 |
負債合計 | 299,198 | 297,186 |
純資産の部 | | |
株主資本 | | |
資本金 | 4,717 | 4,717 |
資本剰余金 | 7,841 | 7,842 |
利益剰余金 | 150,502 | 151,815 |
自己株式 | △5,586 | △5,584 |
株主資本合計 | 157,474 | 158,790 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 228 | 323 |
為替換算調整勘定 | 13,921 | 18,989 |
その他の包括利益累計額合計 | 14,150 | 19,313 |
純資産合計 | 171,625 | 178,103 |
負債純資産合計 | 470,823 | 475,290 |
E0097445530東和薬品株式会社TOWA PHARMACEUTICAL CO., LTD.通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-04-012026-03-31FY2026-03-312024-04-012025-03-312025-03-311falsefalsefalse455302026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455302026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455302025-04-012026-03-31jppfs_cor:ShareholdersEquityMember455302025-04-012026-03-31jppfs_cor:CapitalStockMember455302025-04-012026-03-31jppfs_cor:CapitalSurplusMember455302025-04-012026-03-31jppfs_cor:RetainedEarningsMember455302025-04-012026-03-31jppfs_cor:TreasuryStockMember455302025-04-012026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455302025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455302025-04-012026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455302024-04-012025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455302024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember455302026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455302025-04-012026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455302025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455302024-04-012025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455302024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember455302024-04-012025-03-31jppfs_cor:CapitalStockMember455302024-04-012025-03-31jppfs_cor:CapitalSurplusMember455302024-04-012025-03-31jppfs_cor:TreasuryStockMember455302024-04-012025-03-31jppfs_cor:ShareholdersEquityMember455302024-04-012025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455302025-03-31jppfs_cor:CapitalStockMember455302025-03-31jppfs_cor:CapitalSurplusMember455302025-03-31jppfs_cor:RetainedEarningsMember455302025-03-31jppfs_cor:TreasuryStockMember455302025-03-31jppfs_cor:ShareholdersEquityMember455302025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455302024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember455302026-05-14455302026-03-31455302025-04-012026-03-31455302025-03-31455302024-03-31455302024-04-012025-03-31455302026-03-31jpcrp_cor:ReportableSegmentsMember455302025-04-012026-03-31jpcrp_cor:ReportableSegmentsMember455302025-03-31jpcrp_cor:ReportableSegmentsMember455302024-04-012025-03-31jpcrp_cor:ReportableSegmentsMember455302026-03-31tse-acedjpfr-45530:DomesticReportableSegmentsMember455302026-03-31tse-acedjpfr-45530:OverseasReportableSegmentsMember455302025-04-012026-03-31tse-acedjpfr-45530:DomesticReportableSegmentsMember455302025-04-012026-03-31tse-acedjpfr-45530:OverseasReportableSegmentsMember455302025-03-31tse-acedjpfr-45530:DomesticReportableSegmentsMember455302025-03-31tse-acedjpfr-45530:OverseasReportableSegmentsMember455302024-04-012025-03-31tse-acedjpfr-45530:DomesticReportableSegmentsMember455302024-04-012025-03-31tse-acedjpfr-45530:OverseasReportableSegmentsMember455302026-03-31jpcrp_cor:ReconcilingItemsMember455302025-04-012026-03-31jpcrp_cor:ReconcilingItemsMember455302024-04-012025-03-31jppfs_cor:RetainedEarningsMember455302026-03-31jppfs_cor:ShareholdersEquityMember455302026-03-31jppfs_cor:CapitalStockMember455302026-03-31jppfs_cor:CapitalSurplusMember455302026-03-31jppfs_cor:RetainedEarningsMember455302026-03-31jppfs_cor:TreasuryStockMember455302024-03-31jppfs_cor:CapitalStockMember455302024-03-31jppfs_cor:CapitalSurplusMember455302024-03-31jppfs_cor:RetainedEarningsMember455302024-03-31jppfs_cor:TreasuryStockMember455302024-03-31jppfs_cor:ShareholdersEquityMember455302025-03-31jpcrp_cor:ReconcilingItemsMember455302024-04-012025-03-31jpcrp_cor:ReconcilingItemsMemberxbrli:pureiso4217:JPY